Nantahala Capital Management - JOURNEY MED CORP ownership

JOURNEY MED CORP's ticker is and the CUSIP is 48115J109. A total of 19 filers reported holding JOURNEY MED CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of JOURNEY MED CORP
ValueSharesWeighting
Q3 2023$955,337
+236.2%
348,663
+95.1%
0.08%
+203.7%
Q2 2023$284,143
-14.8%
178,706
-15.8%
0.03%
+3.8%
Q1 2023$333,400
-23.2%
212,357
-6.0%
0.03%
-7.1%
Q4 2022$433,912225,9960.03%
Other shareholders
JOURNEY MED CORP shareholders Q4 2022
NameSharesValueWeighting ↓
B. Riley Financial, Inc. 864,695$4,652,0000.52%
PERKINS CAPITAL MANAGEMENT INC 140,800$758,0000.51%
Millrace Asset Group, Inc. 113,862$613,0000.36%
AMERICAN FINANCIAL GROUP INC 180,000$968,0000.26%
Cannell Capital 41,108$221,0000.04%
B. Riley Wealth Management, Inc. 15,000$81,0000.01%
Neuberger Berman Group LLC 199,112$1,071,0000.00%
TUDOR INVESTMENT CORP ET AL 10,602$57,0000.00%
Tower Research Capital LLC (TRC) 656$4,0000.00%
GOLDMAN SACHS GROUP INC 35,820$193,0000.00%
View complete list of JOURNEY MED CORP shareholders